How big is the Clinical Trials Software Market?
According to 6Wresearch internal database and industry insights, the clinical trials software market was valued at approximately USD 1.7 billion in 2024 and is projected to reach USD 3.1 billion by 2031, growing at a CAGR of 8.5%.
This growth is fueled by increasing digital transformation in clinical research, rising demand for centralized data management, and growing use of cloud-based eClinical solutions.
Key Growth Drivers of the Clinical Trials Software Market
- An emerging burden of digital data management associated with an increase in complexity and volume of clinical trials
- Heightened use of cloud-based clinical trial system and distant supervising tools
- Need of real-time analytics, electronic data capture and regulatory compliance
- Automation, AI, and machine learning tasks in trial management workflow Integration
- Rising popularity of decentralized and virtual clinical trial in the world
Clinical Trials Software Market Trends
The clinical trials software market is evolving with the emergence of fully integrated platforms combining EDC, CTMS, and ePRO capabilities. Sponsors and CROs are increasingly investing in AI-based solutions for site selection, protocol optimization, and patient recruitment. SaaS-based deployment models are gaining traction due to scalability and lower upfront costs. Asia-Pacific is becoming a fast-growing region, driven by trial expansion and tech innovation.
Emerging Developments in the Clinical Trials Software Market
New developments include blockchain-backed systems to secure data transparency and traceability. Wearable device integration and mobile-first platforms are enhancing patient-centric trials. Vendors are offering modular, interoperable systems for small biotech and large pharma alike. Strategic mergers and partnerships are reshaping the competitive landscape with emphasis on flexible, compliant, and automated solutions.
Major Companies in the Clinical Trials Software Market
- Medidata Solutions
- Veeva Systems Inc.
- Oracle Corporation
- IBM Watson Health
- Parexel International
- Medrio Inc.
- DATATRAK International
- Clario
- Castor EDC
- Aris Global
How big is the clinical trials software market : FAQ's
The clinical trials software market was valued at USD 1.7 billion in 2024 and is projected to reach USD 3.1 billion by 2031.
The clinical trials software market is expected to grow at a CAGR of 8.5% during the forecast period.
Electronic data capture, clinical trial management systems, ePRO, eConsent, and safety monitoring.
Need for efficiency, compliance, remote operations, and digital infrastructure in complex clinical research.
Data privacy concerns, integration with legacy systems, high cost of implementation, and regulatory hurdles.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com